Department of Health and Human Services January 7, 2008 – Federal Register Recent Federal Regulation Documents
Results 1 - 5 of 5
Meeting Being Planned to Obtain Public Input for Ensuring the Safety of Pet Food
The Food and Drug Administration (FDA) is announcing its intention to schedule and hold a public meeting early in 2008 to obtain input from stakeholder groups, including, but not limited to, the Association of American Feed Control Officials (AAFCO), veterinary medical associations, animal health organizations, and pet food manufacturers for the development of ingredient, processing, and labeling standards to ensure the safety of pet food. These standards were mandated by the FDA Amendments Act of 2007 (FDAAA). Date, Time, and Location: The date, time, and location for the 2008 public meeting will be announced in a subsequent notice that will be published in the Federal Register a later date. Addresses: A docket has been opened at FDA to receive any comments in advance of the public meeting. Submit written comments to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to either https://www.fda.gov/dockets/ecomments or https:// www.regulations.gov.
National Institute on Drug Abuse Draft Strategic Plan
The National Institute on Drug Abuse (NIDA) is developing a strategic plan for the next 5 years, and invites the public to provide comments on a draft of this plan. The draft plan will be publicly available through the NIDA Draft Strategic Plan Web page (https:// www.drugabuse.gov/StrategicPlan/) for 30 days from the publication of this Notice. The public is invited to provide comments via the e-mail address or the postal address listed on the NIDA Draft Strategic Plan Web page. Background: NIDA is the lead Federal agency for research on drug abuse and addiction. For the past three decades, NIDA has led the way in supporting research to prevent and treat drug abuse and addiction and mitigate the impact of their consequencesparticularly the spread of HIV/AIDS and other infectious diseases. Given recent revolutionary advances in drug abuse research, NIDA has recently undergone a strategic planning process gathering recommendations from the National Advisory Council on Drug Abuse and from ongoing dialogue with our various stakeholder groups to establish achievable goals and objectives for the future. NIDA's draft Strategic Plan outlines four major goal areas Prevention, Treatment, HIV/AIDS, and Cross Cutting Prioritieseach with Strategic Objectives that will guide NIDA's research agenda for the future. The public is invited to review this draft plan and provide comments. The draft plan may be viewed at https://www.drugabuse.gov/ StrategicPlan/, and hard copies are available by calling 301- 443-1124 or by sending a letter requesting a copy (that includes your mailing address) to: National Institute on Drug Abuse, Attn: Draft Strategic Plan, 6001 Executive Blvd., Suite 5213, MSC 9561, Bethesda, MD 20892-9561. Request for Comments: The public is invited to provide comments on the draft Strategic Plan. Comments may be sent to the email address listed on the NIDA Strategic Planning Web page at https:// www.drugabuse.gov/StrategicPlan/, or to the postal address listed above. Comments Due Date: Comments regarding NIDA's draft Strategic Plan should be submitted via e-mail to stratplan@nida.nih.gov no later than 30 days after the publication of this Notice. Comments mailed to the above postal address must be postmarked by the same date.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
